These findings indicated that both CD4+ T cell and CD8+ T cell response was stronger in NICP than ICP, regardless of the clinical form and clinical severity of TB, but the TB2 tube added to the QFT-Plus did not bring an additional contribution to the sensitivity of the test in active TB. This evidence concerns the gene CD4 and tuberculosis.